PSS14 WHAT COST OF HLA-B5801 GENOTYPING WOULD BE COST EFECTIVE FOR THE PREVENTION OF ALLOPURINOL-INDUCED STEVENS JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS IN THAILAND- ANALYSES USING A DECISION-ANALYTIC MODEL
Abstract
Authors
R Somkrua N Chaiyakunapruk W Tassaneeyakul